汉森制药：8月22日召开董事会会议

Group 1 - The core point of the article is that Hansen Pharmaceutical announced the convening of its sixth board meeting to discuss the appointment of a securities representative and reported its revenue structure for the first half of 2025, with a significant focus on the pharmaceutical industry [1][1][1] Group 2 - For the first half of 2025, Hansen Pharmaceutical's revenue composition shows that the pharmaceutical industry accounts for 99.95% of its total revenue, while other businesses contribute only 0.05% [1][1][1] - As of the report, Hansen Pharmaceutical has a market capitalization of 3.5 billion yuan [1][1][1]